Venus Concept Launches Venus Versa Pro, its new multi-application platform for face and body treatments
November 01 2023 - 7:30AM
Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:
VERO), a global medical aesthetic technology leader, announced
today the commercial launch of its new multi-application platform
Venus Versa Pro in the United States.
Venus Versa Pro supports 10 different
applicators that can be used individually or in combination to
target a wide range of aesthetic conditions, including skin
texture, acne vulgaris, vascular and pigmented lesions, facial
wrinkles and many more.
Leveraging our broad portfolio of innovative
technologies, Venus Versa Pro incorporates the latest advancements
of our Venus VivaMD device, allowing enhanced ablation and
coagulation for deeper skin remodeling and optimal skin resurfacing
results.
Practitioners can also take advantage of the
device’s multi-application approach, offering the unique “Tribella”
treatment, which utilizes the company’s proprietary (MP)2
technology, as well as IPL and NanoFractional RF technologies for
complete rejuvenation.
“The launch of Venus Versa Pro is another major
milestone, demonstrating our strategic commitment to deliver
innovative solutions to our customers, enabling them to expand
their treatment offerings and achieve optimal results in a
personalized manner for their patients,” said Dr. Hemanth Varghese,
President and Chief Operating Officer. “Venus Versa Pro is our
first platform product to launch following our recently announced
Venus Aesthetic Intelligence (“Venus AI”) rebrand. It reflects our
new vision for the Company and our forward-looking brand focus. We
look forward to introducing superior, comprehensive technologies
under the Venus AI branding with additional product launches in
2024. “
"The advancements we are introducing in the new
Venus Versa Pro will provide our customers with an enhanced user
experience and superior clinical performance. The system’s ability
to support 10 different applicators will address the growing demand
for multi-modal solutions in aesthetics and offer a complete
rejuvenation solution addressing tone, texture, and tightness,"
said Ross Portaro, EVP, and General Manager, Global Sales and
Marketing. "Venus Versa has been one of the company’s best-selling
products over the last 5 years with thousands of installations
worldwide. We are confident that this next-generation Venus Versa
Pro can build on the success of Venus Versa and be an important
contributor to our revenue growth in 2024 and beyond."
Full commercial launch of Venus Versa Pro begins
today with systems broadly available across the United States.
Cautionary Statement Regarding
Forward-Looking Statements
This communication contains “forward-looking”
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended and Section 21E of the Securities Exchange Act
of 1934, as amended. Any statements contained herein that are not
of historical facts may be deemed to be forward-looking statements.
In some cases, you can identify these statements by words such as
such as “anticipates,” “believes,” “plans,” “expects,” “projects,”
“future,” “intends,” “may,” “should,” “could,” “estimates,”
“predicts,” “potential,” “continue,” “guidance,” and other similar
expressions that are predictions of or indicate future events and
future trends. These forward-looking statements include, but are
not limited to, statements about our financial performance; the
growth in demand for our systems and other products; the
contribution of the Venus Versa Pro to our revenue; and the
efficacy of the Venus Versa Pro and involve risks and uncertainties
that may cause results to differ materially from those set forth in
the statements. These forward-looking statements are based on
current expectations, estimates, forecasts, and projections about
our business and the industry in which the Company operates and
management's beliefs and assumptions and are not guarantees of
future performance or developments and involve known and unknown
risks, uncertainties, and other factors that are in some cases
beyond our control. As a result, any or all of our forward-looking
statements in this communication may turn out to be inaccurate.
Factors that could materially affect our business operations and
financial performance and condition include, but are not limited
to, those risks and uncertainties described under Part II Item
1A—“Risk Factors” in our Quarterly Reports on Form 10-Q and Part I
Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2022. You are urged to consider
these factors carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on the
forward-looking statements. The forward-looking statements are
based on information available to us as of the date of this
communication. Unless required by law, the Company does not intend
to publicly update or revise any forward-looking statements to
reflect new information or future events or otherwise.
About Venus Concept
Venus Concept is an innovative global medical
aesthetic technology leader with a broad product portfolio of
minimally invasive and non-invasive medical aesthetic and hair
restoration technologies and reach in over 60 countries and 14
direct markets. Venus Concept’s product portfolio consists of
aesthetic device platforms, including Venus Versa, Venus Legacy,
Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss,
Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus
Concept’s hair restoration systems include NeoGraft® and the ARTAS
iX® Robotic Hair Restoration system. Venus Concept has been backed
by leading healthcare industry growth equity investors including EW
Healthcare Partners (formerly Essex Woodlands), HealthQuest
Capital, Longitude Capital Management, Aperture Venture Partners,
and Masters Special Situations.
Investor Relations Contact:
ICR Westwicke on behalf of Venus Concept:
Mike Piccinino, CFA
VenusConceptIR@westwicke.com
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Aug 2023 to Aug 2024